{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:34:33Z","timestamp":1793799273167,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science of China","doi-asserted-by":"crossref","award":["82104406"],"award-info":[{"award-number":["82104406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Fujian Province","award":["2021J01922"],"award-info":[{"award-number":["2021J01922"]}]},{"name":"the Fujian University of Traditional Chinese Medicine Foundation","award":["X2019004"],"award-info":[{"award-number":["X2019004"]}]},{"name":"the Fujian University of Traditional Chinese Medicine Foundation","award":["701200001"],"award-info":[{"award-number":["701200001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Curcumin (Cur), a bioactive component of Chinese traditional medicine, has demonstrated inhibitory properties against cancer cell proliferation while synergistically enhancing the anticancer efficacy of erlotinib (Er). However, the individual limitations of both drugs, including poor aqueous solubility, lack of targeting ability, short half-life, etc., and their distinct pharmacokinetic profiles mitigate or eliminate their combined antitumor potential.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, we developed a molybdenum disulfide (MoS<jats:sub>2<\/jats:sub>)-based delivery system, functionalized with polyethylene glycol (PEG) and biotin, and co-loaded with Cur and Er, to achieve efficient cancer therapy. The MoS<jats:sub>2<\/jats:sub>-PEG-Biotin-Cur\/Er system effectively converted near-infrared (NIR) light into heat, thereby inducing direct photothermal ablation of cancer cells and promoting controlled release of Cur and Er. Biotin-mediated tumor targeting facilitated the selective accumulation of MoS<jats:sub>2<\/jats:sub>-PEG-Biotin-Cur\/Er at the tumor site, thus enhancing the synergistic antitumor effects of Cur and Er. Remarkably, MoS<jats:sub>2<\/jats:sub>-PEG-Biotin-Cur\/Er achieved the combination of synergistic chemotherapy and photothermal therapy (PTT) upon NIR irradiation, effectively suppressing lung cancer cell proliferation and inhabiting tumor growth in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The as-synthesized MoS<jats:sub>2<\/jats:sub>-PEG-Biotin-Cur\/Er, featuring high targeting ability, NIR light-responsive drug release, and the integration of synergistic chemotherapy and PTT, may provide a promising strategy for the treatment of lung cancer in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12951-023-02099-4","type":"journal-article","created":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T12:01:25Z","timestamp":1694865685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Targeted co-delivery of curcumin and erlotinib by MoS2 nanosheets for the combination of synergetic chemotherapy and photothermal therapy of lung cancer"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhihuai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunru","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"2099_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2099_CR2","doi-asserted-by":"publisher","DOI":"10.15212\/AMM-2023-1001","author":"SB Zhang","year":"2022","unstructured":"Zhang SB, Hong M, Sun XY, Huang DN, He DH, Chen YF, Yuan Y, Liu Y-Q. Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of skp2. Acta Mater Med. 2022. https:\/\/doi.org\/10.15212\/AMM-2023-1001.","journal-title":"Acta Mater Med"},{"key":"2099_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","volume":"61","author":"PT Harrison","year":"2020","unstructured":"Harrison PT, Vyse S, Huang PH. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Semin Cancer Biol. 2020;61:167\u201379.","journal-title":"Semin Cancer Biol"},{"key":"2099_CR4","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.cllc.2021.10.009","volume":"23","author":"H Hayashi","year":"2022","unstructured":"Hayashi H, Nadal E, Gray JE, Ardizzoni A, Caria N, Puri T, Grohe C. Overall treatment strategy for patients with metastatic NSCLC with activating EGFR mutations. Clin Lung Cancer. 2022;23:e69\u201382.","journal-title":"Clin Lung Cancer"},{"key":"2099_CR5","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1158\/1078-0432.CCR-17-2961","volume":"24","author":"HA Yu","year":"2018","unstructured":"Yu HA, Suzawa K, Jordan E, Zehir A, Ni A, Kim R, Kris MG, Hellmann MD, Li BT, Somwar R. Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistanceconcurrent alterations in EGFR-mutant lung cancers. Clin Cancer Res. 2018;24:3108\u201318.","journal-title":"Clin Cancer Res"},{"key":"2099_CR6","doi-asserted-by":"publisher","first-page":"eabg6428","DOI":"10.1126\/scitranslmed.abg6428","volume":"13","author":"KR Zhang","year":"2021","unstructured":"Zhang KR, Zhang YF, Lei HM, Tang YB, Ma CS, Lv QM, Wang SY, Lu LM, Shen Y, Chen HZ. Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR-targeted therapy in lung cancer. Sci Transl Med. 2021;13:eabg6428.","journal-title":"Sci Transl Med."},{"key":"2099_CR7","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.2174\/1381612823666170123143648","volume":"23","author":"M Shafiee","year":"2017","unstructured":"Shafiee M, Mohamadzade E, ShahidSales S, Khakpouri S, Maftouh M, Alireza Parizadeh S, Mahdi Hasanian S, Avan A. Current status and perspectives regarding the therapeutic potential of targeting EGFR pathway by curcumin in lung cancer. Curr Pharm Des. 2017;23:2002\u20138.","journal-title":"Curr Pharm Des"},{"key":"2099_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3727\/096504013X13832473330032","volume":"21","author":"S Li","year":"2014","unstructured":"Li S, Liu Z, Zhu F, Fan X, Wu X, Zhao H, Jiang L. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor. Oncol Res. 2014;21:137\u201344.","journal-title":"Oncol Res"},{"key":"2099_CR9","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.2147\/CMAR.S159660","volume":"10","author":"X Dai","year":"2018","unstructured":"Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G. A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction. Cancer Manag Res. 2018;10:3069.","journal-title":"Cancer Manag Res"},{"key":"2099_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ptr.5984","volume":"32","author":"S Javadi","year":"2018","unstructured":"Javadi S, Rostamizadeh K, Hejazi J, Parsa M, Fathi M. Curcumin mediated down-regulation of \u03b1V\u03b23 integrin and up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cells. Phytother Res. 2018;32:355\u201364.","journal-title":"Phytother Res"},{"key":"2099_CR11","doi-asserted-by":"publisher","first-page":"10281","DOI":"10.1002\/jcp.27933","volume":"234","author":"A Hesari","year":"2019","unstructured":"Hesari A, Rezaei M, Rezaei M, Dashtiahangar M, Fathi M, Rad JG, Momeni F, Avan A, Ghasemi F. Effect of curcumin on glioblastoma cells. J Cell Physiol. 2019;234:10281\u20138.","journal-title":"J Cell Physiol"},{"key":"2099_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/ptr.5056","volume":"28","author":"Y Yamauchi","year":"2014","unstructured":"Yamauchi Y, Izumi Y, Yamamoto J, Nomori H. Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. Phytother Res. 2014;28:728\u201335.","journal-title":"Phytother Res"},{"key":"2099_CR13","doi-asserted-by":"publisher","first-page":"154339","DOI":"10.1016\/j.prp.2023.154339","volume":"243","author":"S Ghafouri-Fard","year":"2023","unstructured":"Ghafouri-Fard S, Poornajaf Y, Hussen BM, Avval ST, Taheri M, Mokhtari M. Deciphering the role of Hippo pathway in lung cancer. Pathol-Res Pract. 2023;243:154339.","journal-title":"Pathol-Res Pract"},{"key":"2099_CR14","doi-asserted-by":"publisher","first-page":"23953","DOI":"10.1039\/D0NR06945K","volume":"12","author":"Y Wang","year":"2020","unstructured":"Wang Y, Cheng J, Zhao D, Liu Y, Luo T, Zhong YF, Mo F, Kong XY, Song J. Designed DNA nanostructure grafted with erlotinib for non-small-cell lung cancer therapy. Nanoscale. 2020;12:23953\u20138.","journal-title":"Nanoscale"},{"key":"2099_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08982104.2022.2086567","volume":"33","author":"MA Obeid","year":"2023","unstructured":"Obeid MA, Alsaadi M, Aljabali AA. Recent updates in curcumin delivery. J Liposome Res. 2023;33:53\u201364.","journal-title":"J Liposome Res"},{"key":"2099_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12951-022-01524-4","volume":"20","author":"Y Ruan","year":"2022","unstructured":"Ruan Y, Xiong Y, Fang W, Yu Q, Mai Y, Cao Z, Wang K, Lei M, Xu J, Liu Y. Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer\u2019s disease via NLRP3-inhibition. J Nanobiotechnology. 2022;20:322.","journal-title":"J Nanobiotechnology"},{"key":"2099_CR17","first-page":"312","volume":"13","author":"D Wang","year":"2022","unstructured":"Wang D, Zhou J, Fang W, Huang C, Chen Z, Fan M, Zhang M-R, Xiao Z, Hu K, Luo L. A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer. Bioact Mater. 2022;13:312\u201323.","journal-title":"Bioact Mater"},{"key":"2099_CR18","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.1039\/D1CS00236H","volume":"50","author":"X Yin","year":"2021","unstructured":"Yin X, Tang CS, Zheng Y, Gao J, Wu J, Zhang H, Chhowalla M, Chen W, Wee AT. Recent developments in 2D transition metal dichalcogenides: phase transition and applications of the (quasi-) metallic phases. Chem Soc Rev. 2021;50:10087\u2013115.","journal-title":"Chem Soc Rev"},{"key":"2099_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmatsci.2021.100838","volume":"121","author":"A Gupta","year":"2021","unstructured":"Gupta A, Ghosh S, Thakur MK, Zhou J, Ostrikov KK, Jin D, Chattopadhyay S. Up-conversion hybrid nanomaterials for light-and heat-driven applications. Prog Mater Sci. 2021;121: 100838.","journal-title":"Prog Mater Sci"},{"key":"2099_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jconrel.2022.05.047","volume":"348","author":"A Sethulekshmi","year":"2022","unstructured":"Sethulekshmi A, Saritha A, Joseph K, Aprem AS, Sisupal SB. MoS2 based nanomaterials: advanced antibacterial agents for future. J Control Release. 2022;348:158\u201385.","journal-title":"J Control Release"},{"key":"2099_CR21","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1039\/D0TB01018A","volume":"8","author":"J Shi","year":"2020","unstructured":"Shi J, Li J, Wang Y, Cheng J, Zhang CY. Recent advances in MoS2-based photothermal therapy for cancer and infectious disease treatment. J Mater Chem B. 2020;8:5793\u2013807.","journal-title":"J Mater Chem B"},{"key":"2099_CR22","first-page":"4209","volume":"6","author":"J Wang","year":"2021","unstructured":"Wang J, Sui L, Huang J, Miao L, Nie Y, Wang K, Yang Z, Huang Q, Gong X, Nan Y. MoS2-based nanocomposites for cancer diagnosis and therapy. Bioact Mater. 2021;6:4209\u201342.","journal-title":"Bioact Mater"},{"key":"2099_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2020.12.015","volume":"330","author":"N Dhas","year":"2021","unstructured":"Dhas N, Kudarha R, Garkal A, Ghate V, Sharma S, Panzade P, Khot S, Chaudhari P, Singh A, Paryani M. Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: current advancement and future breakthroughs. J Control Release. 2021;330:257\u201383.","journal-title":"J Control Release"},{"key":"2099_CR24","doi-asserted-by":"publisher","first-page":"8751","DOI":"10.1039\/D1NR00323B","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng H-M, Li Z. Near-infrared inorganic nanomaterial-based nanosystems for photothermal therapy. Nanoscale. 2021;13:8751\u201372.","journal-title":"Nanoscale"},{"key":"2099_CR25","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1002\/adma.201305256","volume":"26","author":"T Liu","year":"2014","unstructured":"Liu T, Wang C, Gu X, Gong H, Cheng L, Shi X, Feng L, Sun B, Liu Z. Drug delivery with PEGylated MoS2 nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater. 2014;26:3433\u201340.","journal-title":"Adv Mater"},{"key":"2099_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcis.2019.04.022","volume":"548","author":"J Liu","year":"2019","unstructured":"Liu J, Zheng J, Nie H, Zhang D, Cao D, Xing Z, Li B, Jia L. Molybdenum disulfide-based hyaluronic acid-guided multifunctional theranostic nanoplatform for magnetic resonance imaging and synergetic chemo-photothermal therapy. J Colloid Interface Sci. 2019;548:131\u201344.","journal-title":"J Colloid Interface Sci"},{"key":"2099_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-019-0510-2","volume":"17","author":"J Liu","year":"2019","unstructured":"Liu J, Li F, Zheng J, Li B, Zhang D, Jia L. Redox\/NIR dual-responsive MoS2 for synergetic chemo-photothermal therapy of cancer. J Nanobiotechnology. 2019;17:1\u201316.","journal-title":"J Nanobiotechnology"},{"key":"2099_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2019.122541","volume":"381","author":"J Liu","year":"2020","unstructured":"Liu J, Zheng J, Nie H, Chen H, Li B, Jia L. Co-delivery of erlotinib and doxorubicin by MoS2 nanosheets for synergetic photothermal chemotherapy of cancer. Chem Eng J. 2020;381: 122541.","journal-title":"Chem Eng J"},{"key":"2099_CR29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/pharmaceutics12090798","volume":"12","author":"PK Bolla","year":"2020","unstructured":"Bolla PK, Gote V, Singh M, Patel M, Clark BA, Renukuntla J. Lutein-loaded, biotin-decorated polymeric nanoparticles enhance lutein uptake in retinal cells. Pharmaceutics. 2020;12:798.","journal-title":"Pharmaceutics"},{"key":"2099_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijbiomac.2021.07.197","volume":"188","author":"V Balan","year":"2021","unstructured":"Balan V, Dodi G, Mihai C, Serban A, Ursachi V. Biotinylated chitosan macromolecule based nanosystems: a review from chemical design to biological targets. Int J Biol Macromol. 2021;188:82\u201393.","journal-title":"Int J Biol Macromol"},{"key":"2099_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jconrel.2023.03.051","volume":"357","author":"H Li","year":"2023","unstructured":"Li H, Bruce G, Childerhouse N, Keegan G, Mantovani G, Stolnik S. Biotin receptor-mediated intracellular delivery of synthetic polypeptide-protein complexes. J Control Release. 2023;357:333\u201341.","journal-title":"J Control Release"},{"key":"2099_CR32","doi-asserted-by":"publisher","first-page":"12342","DOI":"10.1021\/acsnano.1c04280","volume":"15","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liu B, Sun Q, Feng L, He F, Yang P, Gai S, Quan Z, Lin J. Upconverted metal\u2013organic framework janus architecture for near-infrared and ultrasound co-enhanced high performance tumor therapy. ACS Nano. 2021;15:12342\u201357.","journal-title":"ACS Nano"},{"key":"2099_CR33","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.cclet.2021.08.111","volume":"33","author":"X Song","year":"2022","unstructured":"Song X, Wang R, Gao J, Han X, Jin J, Lv C, Yu F. Construction of a biotin-targeting drug delivery system and its near-infrared theranostic fluorescent probe for real-time image-guided therapy of lung cancer. Chin Chem Lett. 2022;33:1567\u201371.","journal-title":"Chin Chem Lett"},{"key":"2099_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202116807","volume":"134","author":"L Liu","year":"2022","unstructured":"Liu L, Liu F, Liu D, Yuan W, Zhang M, Wei P, Yi T. A smart theranostic prodrug system activated by reactive oxygen species for regional chemotherapy of metastatic cancer. Angew Chem. 2022;134: e202116807.","journal-title":"Angew Chem"},{"key":"2099_CR35","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1021\/ja310929s","volume":"135","author":"SS Chou","year":"2013","unstructured":"Chou SS, De M, Kim J, Byun S, Dykstra C, Yu J, Huang J, Dravid VP. Ligand conjugation of chemically exfoliated MoS2. J Am Chem Soc. 2013;135:4584\u20137.","journal-title":"J Am Chem Soc"},{"key":"2099_CR36","doi-asserted-by":"publisher","first-page":"1701158","DOI":"10.1002\/adhm.201701158","volume":"7","author":"T Liu","year":"2018","unstructured":"Liu T, Liu Z. 2D MoS2 nanostructures for biomedical applications. Adv Healthc Mater. 2018;7:1701158.","journal-title":"Adv Healthc Mater"},{"key":"2099_CR37","doi-asserted-by":"publisher","first-page":"7117","DOI":"10.1002\/adma.201503869","volume":"27","author":"S Wang","year":"2015","unstructured":"Wang S, Chen Y, Li X, Gao W, Zhang L, Liu J, Zheng Y, Chen H, Shi J. Injectable 2D MoS2-integrated drug delivering implant for highly efficient NIR-triggered synergistic tumor hyperthermia. Adv Mater. 2015;27:7117\u201322.","journal-title":"Adv Mater"},{"key":"2099_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01427-4","volume":"20","author":"R-T Li","year":"2022","unstructured":"Li R-T, Zhu Y-D, Li W-Y, Hou Y-K, Zou Y-M, Zhao Y-H, Zou Q, Zhang W-H, Chen J-X. Synergistic photothermal-photodynamic-chemotherapy toward breast cancer based on a liposome-coated core\u2013shell AuNS@ NMOFs nanocomposite encapsulated with gambogic acid. J Nanobiotechnology. 2022;20:1\u201322.","journal-title":"J Nanobiotechnology"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-02099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-02099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T17:21:59Z","timestamp":1700328119000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-02099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-02099-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,16]]},"assertion":[{"value":"10 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted according to animal protocol procedures approved by the Institutional Animal Care and Use Committee (IACUC) of Fujian University of Traditional Chinese Medicine, which are consistent with the American Association for Laboratory Animal Science (AALAS) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}